当前位置: X-MOL 学术Am. J. Cardiol. › 论文详情
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.
The American Journal of Cardiology ( IF 2.570 ) Pub Date : 2020-09-16 , DOI: 10.1016/j.amjcard.2020.09.012
Lori B Daniels,Amy M Sitapati,Jing Zhang,Jingjing Zou,Quan M Bui,Junting Ren,Christopher A Longhurst,Michael H Criqui,Karen Messer

The impact of statins, ACE inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) on COVID-19 severity and recovery is important given their high prevalence of use among individuals at risk for severe COVID-19. We studied the association between use of statin/ACEi/ARB in the month before hospital admission, with risk of severe outcome, and with time to severe outcome or disease recovery, among patients hospitalized for COVID-19. We performed a retrospective single-center study of all patients hospitalized at UCSD Health between February 10-June 17, 2020 (n=170 hospitalized for COVID-19, n=5281 COVID-negative controls). Logistic regression and competing risks analyses were used to investigate progression to severe disease (death or intensive care unit admission), and time to discharge without severe disease. Severe disease occurred in 53% of COVID-positive inpatients. Median time from hospitalization to severe disease was 2 days; median time to recovery was 7 days. Statin use prior to admission was associated with reduced risk of severe COVID-19 (adjusted OR 0.29, 95% CI 0.11-0.71, p<0.01) and faster time to recovery among those without severe disease (adjusted HR for recovery 2.69, 95% CI 1.36-5.33, p<0.01). The association between statin use and severe disease was smaller in the COVID-negative cohort (p for interaction=0.07). There was potential evidence of faster time to recovery with ARB use (aHR 1.92, 95% CI 0.81-4.56). In conclusion, statin use during the 30 days prior to admission for COVID-19 was associated with a lower risk of developing severe COVID-19, and a faster time to recovery among patients without severe disease.

更新日期:2020-09-16

 

全部期刊列表>>
Springer 纳米技术权威期刊征稿
全球视野覆盖
施普林格·自然新
chemistry
3分钟学术视频演讲大赛
物理学研究前沿热点精选期刊推荐
自然职位线上招聘会
欢迎报名注册2020量子在线大会
化学领域亟待解决的问题
材料学研究精选新
GIANT
ACS ES&T Engineering
ACS ES&T Water
屿渡论文,编辑服务
ACS Publications填问卷
阿拉丁试剂right
西北大学
大连理工大学
湖南大学
华东师范大学
王要兵
浙江大学
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
天合科研
x-mol收录
陆军军医大学
李霄鹏
廖矿标
试剂库存
down
wechat
bug